Immune-mediated dormancy: an equilibrium with cancer
Top Cited Papers
- 30 May 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 84 (4) , 988-993
- https://doi.org/10.1189/jlb.1107774
Abstract
This brief review discusses the role of the immune system in tumor development, covering a history of cancer immunity and a summary of the concept of cancer immunoediting, including its three phases: elimination, equilibrium, and escape. The latter half of this review then focuses specifically on the equilibrium phase, making note of previous work, suggesting that immunity might maintain cancer in a dormant state, and concluding with a description of a tractable mouse model unequivocally demonstrating that immunity can indeed hold preformed cancer in check. These findings form a framework for future studies aimed at validating immune-mediated cancer dormancy in humans with the hopes of devising new, immunotherapeutic strategies to treat established cancer.Keywords
Funding Information
- National Health and Medical Research of Australia
This publication has 41 references indexed in Scilit:
- Models, mechanisms and clinical evidence for cancer dormancyNature Reviews Cancer, 2007
- Immune surveillance of tumorsJournal of Clinical Investigation, 2007
- Spontaneous tumor rejection by cbl-b–deficient CD8+ T cellsThe Journal of Experimental Medicine, 2007
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- Relapse of Stage I Small Cell Lung Cancer Ten or More Years after the Start of TreatmentJapanese Journal of Clinical Oncology, 2006
- Telomerase activity in disseminated prostate cancer cellsBJU International, 2006
- Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: Case report and review of the literatureAmerican Journal of Hematology, 2006
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancyBreast Cancer Research and Treatment, 1996